Skip to main content
رجوع
Watch Compare

Cresco Labs Inc.

جودة البيانات: 100%
CRLBF
OTC Manufacturing Chemicals
KWD 0.94
▼ KWD 0.04 (-4.10%)
6 months return
—
Momentum
Neutral
ROE
-33.22%

النمو

Revenue Growth (5Y)
N/A
Revenue (1Y)-9.46%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
-33.22%
أعلى من متوسط القطاع (-54.47%)
ROIC-1.86%
Net Margin-20.65%
Op. Margin-4.27%

الأمان

Debt / Equity
1.26
أعلى من متوسط القطاع (0.30)
Current Ratio2.59
Interest Coverage-0.67

التقييم

PE (TTM|NTM)
-2.55 | -8.86
أقل من متوسط القطاع (-1.50)
P/B Ratio1.02
EV/EBITDA34.54
Dividend YieldN/A

Quick Summary

Key Takeaways

Short bullets derived from reported financials—not the AI summary above.

Generating 37.75 M in free cash flow
Capital efficient — spends only 5.36% of revenue on capex

Price History

الاتجاهات المالية

السعر المستهدف للمحللين

محلل 1
Buy
+113.9%
upside to target
الحالي
KWD 0.94
Consensus Target
KWD 2.00
KWD 2.00
أدنى
KWD 2.00
أعلى
التوقعات
مكرر الربحية المستقبلي
-8.86
ربحية السهم المستقبلية
-KWD 0.11
الإيرادات المقدّرة
651.84 M

مفاجآت الأرباح

EPS
Reported Estimate Forecast
Next: Q1 2026 · EPS Est: -KWD 0.04 · Rev Est: 148.88 M
Q12025 Q22025 Q32025 Q42025 Q1 '26 Q2 '26
Reported KWD 0.02 -KWD 0.02 KWD 0.01 -KWD 0.03 — —
Estimate -KWD 0.03 -KWD 0.04 -KWD 0.04 -KWD 0.03 -KWD 0.04 -KWD 0.03
المفاجأة +187.04% +51.62% +120.37% +10.36% — —

Growth

Rev 5Y: N/A · Earnings 1Y: N/A
Revenue Growth (1Y) -9.46% Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A

Profitability

ROE: -33.22% · Net Margin: -20.65%
Revenue (TTM) 655.85 M Net Income (TTM) -135.41 M
ROE -33.22% ROA -10.61%
Gross Margin 49.49% Operating Margin -4.27%
Net Margin -20.65% Free Cash Flow (TTM) 37.75 M
ROIC -1.86% FCF Growth (3Y) N/A

Safety

D/E: 1.26 · Current: 2.59
Debt / Equity 1.26 Current Ratio 2.59
Interest Coverage -0.67 Asset Turnover 0.51
Working Capital 159.09 M Tangible Book Value -143.07 M

Dividends

Yield: N/A · Payout: N/A
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A

Valuation

P/E: -2.55 · EV/EBITDA: 34.54
P/E Ratio -2.55 Forward P/E -8.86
P/B Ratio 1.02 P/S Ratio 0.53
PEG Ratio N/A Forward PEG N/A
EV/EBITDA 34.54 Fwd EV/EBITDA N/A
Forward P/S 0.53 Fwd Earnings Yield N/A
FCF Yield 10.92%
Market Cap 345.87 M Enterprise Value 715.85 M

Per Share

EPS: -0.38 · FCF/Share: 0.11
EPS (Diluted TTM) -0.38 Revenue / Share 1.82
FCF / Share 0.11 OCF / Share 0.20
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A

Efficiency

FCF Conv: -27.88% · CapEx/Rev: 5.36%
CapEx / Revenue 5.36% FCF Conversion -27.88%
SBC-Adj. FCF 26.52 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024
Revenue 655.85 M 724.34 M
Net Income -135.41 M -74.44 M
EPS (Diluted) -0.38 -0.22
Gross Profit 324.57 M 364.45 M
Operating Income -27.99 M 107.29 M
EBITDA — —
R&D Expenses — —
SG&A Expenses 247.45 M 254.84 M
D&A 48.71 M 59.10 M
Interest Expense 41.75 M 37.93 M
Income Tax 44.62 M 49.87 M

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024
Total Assets 1.20 B 1.36 B
Total Liabilities 944.80 M 967.18 M
Shareholders' Equity 340.45 M 474.85 M
Total Debt 427.88 M 472.68 M
Cash & Equivalents 57.90 M 137.56 M
Current Assets 259.27 M 294.26 M
Current Liabilities 100.18 M 94.34 M

مقارنة الأقران

مقابل وسيط قطاع Manufacturing (1605 نظير)
المقياس السهم وسيط القطاع
P/E -2.6 -1.5
P/B 1.0 1.6
ROE % -33.2 -54.5
Net Margin % -20.7 -41.5
Rev Growth 5Y % — 1.9
D/E 1.3 0.3